*恭喜浙江省农业科学院俞老师在SCI期刊 Environmental Science and Pollution Research(IF:2.914)上成功发表
*恭喜西安理工大学张老师,环境水利专业,文章成功发表在SCI期刊Environmental Science and Pollution Research上,IF2.914
*恭喜山东交通学院谢老师在SCI期刊APPLIED SURFACE SCIENCE(IF5.15)上成功发表
*恭喜华中科技大学黄老师在SCI期刊 ACS Applied Materials & Interfaces(IF8.456)上成功发表
*恭喜中南大学湘雅医院黄医生在Frontiers in Oncology(IF 4.137)上成功发表
*恭喜复旦大学辛博士在SCI期刊 FEBS LETTERS(IF2.675)上成功发表
*恭喜中南大学陈博士在THIN-WALLED STRUCTURESSCI期刊(IF3.488)上成功发表
*恭喜湖南工学院郭老师在SCI期刊SIMULATION MODELLING PRACTICE AND THEORY(IF2.42)上成功发表
*恭喜东华大学闫老师在SCI期刊Advanced Functional Materials(IF 15.621)上成功发表
*恭喜安徽医科大学肖老师在SCI期刊BMC CELL BIOLOGY(IF 3.485)上成功发表
*恭喜四川大学华西医院谢医生在SCI期刊European Heart Journal: Acute Cardiovascular Care(IF 3.734)上成功发表

0591-83301811

周一~周日, 8:00 - 23:00

13107667616

周一~周日, 8:00 - 23:00

service@editideas.cn

随时欢迎您的来信!

2021年最新SCI期刊影响因子查询系统

期刊名称:
ISSN:
期刊研究方向:
IF范围:
中科院分区:
SCI/SCIE:
是否OA期刊:
排列方式:

PULMONARY PHARMACOLOGY & THERAPEUTICS 期刊详细信息

基本信息
期刊名称 PULMONARY PHARMACOLOGY & THERAPEUTICS
PULMONARY PHARMACOLOGY & THERAPEUTICS
期刊ISSN 1094-5539
期刊官方网站 http://www.journals.elsevier.com/pulmonary-pharmacology-and-therapeutics/#description
是否OA
出版商 Academic Press Inc.
出版周期 Bimonthly
始发年份 1997
年文章数 96
最新影响因子 3.282(2021)
中科院SCI期刊分区
大类学科 小类学科 Top 综述
医学3区 PHARMACOLOGY & PHARMACY 药学3区
RESPIRATORY SYSTEM 呼吸系统4区
CiteScore
CiteScore排名 CiteScore SJR SNIP
学科 排名 百分位 2.74 0.952 0.809
Medicine
Biochemistry, medical
14 / 51 73%
Medicine
Pulmonary and Respiratory Medicine
32 / 134 76%
Medicine
Pharmacology (medical)
66 / 232 71%
补充信息
自引率 7.10%
H-index 61
SCI收录状况 Science Citation Index Expanded
官方审稿时间
网友分享审稿时间 数据统计中,敬请期待。
PubMed Central (PML) http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1094-5539%5BISSN%5D
投稿指南
期刊投稿网址 https://www.evise.com/evise/faces/pages/navigation/NavController.jspx?
收稿范围
Pulmonary Pharmacology and Therapeutics (formerly Pulmonary Pharmacology) is concerned with lung pharmacology from molecular to clinical aspects. The subject matter encompasses the major diseases of the lung including asthma, cystic fibrosis, pulmonary circulation, ARDS, carcinoma, bronchitis, emphysema and drug delivery. Laboratory and clinical research on man and animals will be considered including studies related to chemotherapy of cancer, tuberculosis and infection. In addition to original research papers the journal will include review articles and book reviews.
Research Areas Include:
• All major diseases of the lung
• Physiology
• Pathology
• Drug delivery
• Metabolism
• Pulmonary Toxicology
Before submitting, please note the "Rules of 5" defining immediate rejection criteria of PPT:
1. Out of scope: The paper should report on the use of pharmacological or toxicological studies (positive or negative) that are directly related to Pulmonary Pharmacology & Therapeutics.
Immediate rejection criteria are:
a) Testing of extracts or plant parts that are not characterized
b) Case Reports or n=1 studies
2. Too preliminary: A paper must be based on a thorough and extensive study, using proper controls
Immediate rejection criteria are:
a) In vitro studies with a single dose, or very high concentration b) Single dose studies with very few animals, no dose-response studies c) No proper controls. d) Repetition or confirmation of an earlier work
3. Unethical: The study must have been carried under appropriate ethical approval for the study (either animal or human).
4. Inappropriate experiments or lacking essential detail
Immediate rejection criteria are: a) Wrong species or lacking details on the exact number of animals/subjects used
b) No details of structure if a new drug is used for the first time
5. Lack of novelty: The study must represent a novel approach to the field.
Immediate rejection criteria are:
a) Repetition of well known data
b) No advance of knowledge in the field
Note that only manuscripts written in good English will be considered by the Editors(British usage is preferred).
收录体裁
original research papers
review articles
book reviews. 
投稿指南 https://www.elsevier.com/journals/pulmonary-pharmacology-and-therapeutics/1094-5539/guide-for-authors
投稿模板
参考文献格式 https://www.elsevier.com/journals/pulmonary-pharmacology-and-therapeutics/1094-5539/guide-for-authors
编辑信息
近期成功发表案例展示